FdaApplication

NDA 022563

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMAYNE PHARMA LLC
application_typeNDA
approval_date2010-10-06

Products (1)

ProductActive ingredientStrengthDosage form
SORILUXCALCIPOTRIENE0.005%AEROSOL, FOAM;TOPICAL

1 product